Replies to post #307661 on Anavex Life Sciences Corp (AVXL)

[ignatiusrielly35]

Who cares either way? If so, hold and buy more.

[dholmes791]

The stock has moved this year because of near term catalysts...not "basically nothing".

-- Complete data ANAVEX®2-73 U.S. Rett syndrome Phase 2 study – expected Q2 2021
-- Complete data ANAVEX®2-73 Parkinson’s disease dementia (PDD) Phase 2 study – expected Q2 2021
-- Top-line data AVATAR: Potentially pivotal Phase 2/3 adult RTT clinical trial – expected mid 2021
-- Top-line data Phase 1 ANAVEX®3-71 clinical trial – expected mid 2021
-- Top-line data EXCELLENCE: Potentially pivotal Phase 2/3 pediatric RTT clinical trial – expected 2H
2021
-- Top-line data ANAVEX®2-73-AD-004: Potentially pivotal Phase 2b/3 AD clinical trial – expected 1H 2022
-- Initiation of ANAVEX®2-73 imaging-focused Parkinson’s disease clinical trial – expected 2021
-- Pipeline expansion opportunities for ANAVEX®2-73
-- Initiation of potentially pivotal Phase 2/3 Fragile X clinical trial – expected 2021
-- Initiation of potentially pivotal Phase 2/3 clinical trial for the treatment of a new, rare disease
indication – expected 2021

~ 230M shares have traded between 11$-28$. That's over 3x the current O/S of 70,030,620(March 29, 2021)

Seems like it has consolidated well in this $11-$16 range. Volume feels relatively anemic at the lower end of this range.

[nidan7500]

Ggator328-Read this and review the recent webcast.

AMAZING work being done by Anavex.

https://wsw.com/webcast/needham107/avxl/2271566

I encourage anyone who has not listened carefully to this recent presentation to do so. Dr.M. is obviously fully engaged in these studies as a technical/logical leader. He not only talks to specifics from our trials as he describes the results but he he also discusses WHY we are seeing what we are seeing in what he describes as, "the upstream biological systems". Defining WHY these facts are important and how the pieces fit together

Anavex will be meeting w/FDA soon. He says trial data will be published this Quarter, Q2- CY 21. All very credible technically and compelling as disciplined investors and regulatory bodies await timely fresh CNS disease developments.

Strongly suggest every AVXL investor must listen to this comprehensive description of this little company's impressive scientific-clinical work.

There is an old expression that pilots use, "Never get behind the airplane". It literally means, if you do get behind the airplane you are at great risk. Staying ahead of the airplane can be tough at times but it is not optional.

IMO, after studying this webcast video I am convinced that Dr.M. is ahead of the AVXL CNS disease airplane as he must be.

[123tom]

But why would the price have

been holding support at the 11.00-11.30 area like it has several times.in the last 3 months? Capped at the 16 area ,ok, call that a Range top. Now they are deciding to take it below 11? Yes, it could drop dolars to target 8. Ive had my eye on that since february.
It could happen. But I'm nibbling with stink bids around 10.30 for the moment. trading shares, to sell at 13 area. in this short time cycle.
Bottom fishing now, definitely nervous about this 11 dollar cliff edge